Collaboration. Acceleration. Results.
Myelin Repair Foundation Home Page
ANNOUNCEMENT: MRF will be closing its doors this summer, but our guanabenz (MRF-008) clinical trial and the myelin repair research we fostered will live on.

Newsroom

Here is a listing of our current media-related activities and resources along with links to our archive:

Recent Media Coverage

San Francisco Business Times, How a white powder couldn't pass U.S. Customs but could save MS patients, May 1, 2015
Case Western Reserve University - The Daily, Drugs stimulate body’s stem cells to replace the brain cells lost in multiple sclerosis, April 20, 2015
ScienceLife: The University of Chicago, Blood pressure drug protects against symptoms of multiple sclerosis in animal models, March 13, 2015
NeurologyNow, Getting at the Root of MS, December 2014 / January 2015
The New Exploratory Urge, May 2014
Life Science Leader, Life Science Partnerships With Patient Foundations: The Best Practices, June 2, 2014
Pharmaceutical Executive, Pushing the Boundaries of MS Research: The Myelin Repair Foundation, February 28, 2014
Multiple Sclerosis Discovery Forum, MS Research Roundup: February 12, 2014
View entire articles and press coverage archive.

- Back to top -

Recent Press Releases

The Myelin Repair Foundation and National Institutes of Health Initiate Clinical Studies of Guanabenz for Treatment of Multiple Sclerosis (April 30, 2015)
Blood pressure drug protects against symptoms of multiple sclerosis in animal models (March 13, 2015)
Conrad N. Hilton Foundation Grants Myelin Repair Foundation $1.35 Million Matching Grant to Support Myelin Repair Research (November 24, 2014)
Myelin Repair Foundation Announces Long-Term European Partnership with Hertie Foundation (August 11, 2014)
Bionure Inc.’s MS Drug Candidate Shows Positive Results for Myelin Repair in Cell Culture Assay (May 27, 2014)
View entire press release archive.

- Back to top -

Background Information

Myelin Repair Foundation Overview (PDF)
The Myelin Repair Foundation's Translational Medicine Platform (PDF)
View entire background and whitepaper archive.

- Back to top -

Video Interviews and Talks

Hear Myelin Repair Foundation CEO Scott Johnson talk about how we're accelerating research for myelin repair therapeutic drugs for multiple sclerosis.

Mendel's Pod:
When Drug Discovery Gets Personal

Watch When Drug Discovery Gets Personal

12Gurus 2012:
Where are the Cures?